Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Safety and effectiveness of abatacept in Japanese non-elderly and elderly patients with rheumatoid arthritis in an all-cases post-marketing surveillance.

Harigai M, Ishiguro N, Inokuma S, Mimori T, Ryu J, Takei S, Takeuchi T, Tanaka Y, Takasaki Y, Yamanaka H, Yoshizawa Y, Chinen I, Nakao T, Koike T.

Mod Rheumatol. 2018 Oct 25:1-9. doi: 10.1080/14397595.2018.1524998. [Epub ahead of print]

PMID:
30217117
2.

[Status of Hepatic Lymph Node Involvement in Patients with Resectable Liver Metastasis of Colorectal Cancer after Preoperative Chemotherapy].

Ogura T, Muta Y, Hatano S, Amano K, Ishiguro T, Fukuchi M, Inokuma S, Kumagai Y, Ishibashi K, Mochiki E, Ishida H.

Gan To Kagaku Ryoho. 2018 Feb;45(2):339-341. Japanese.

PMID:
29483440
3.

[The Characteristics and Treatment Outcomes for Desmoid Tumors Associated with Familial Adenomatous Polyposis].

Amano K, Chika N, Ito T, Yamamoto A, Hatano S, Ishiguro T, Fukuchi M, Kumagai Y, Ishibashi K, Mochiki E, Iwama T, Eguchi H, Okazaki K, Inokuma S, Ishida H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1449-1451. Japanese.

PMID:
29394664
4.

Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.

Fukuda W, Hanyu T, Katayama M, Mizuki S, Okada A, Miyata M, Handa Y, Hayashi M, Koyama Y, Arii K, Kitaori T, Hagiyama H, Urushidani Y, Yamasaki T, Ikeno Y, Suzuki T, Omoto A, Sugitani T, Morita S, Inokuma S.

Ann Rheum Dis. 2017 Jun;76(6):1051-1056. doi: 10.1136/annrheumdis-2016-209973. Epub 2016 Dec 1.

5.

Effect of Methotrexate Plus Adalimumab on the Achievement of Rheumatoid Arthritis Therapeutic Goals: Post Hoc Analysis of Japanese Patients (MELODY Study).

Koike T, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, Yamanaka H, Takasaki Y, Mimori T, Hiramatsu K, Komatsu S, Tanaka Y.

Rheumatol Ther. 2016 Jun;3(1):129-141. doi: 10.1007/s40744-015-0023-x. Epub 2015 Dec 22.

6.

Thermal Disparity between Fingers after Cold-water Immersion of Hands: A Useful Indicator of Disturbed Peripheral Circulation in Raynaud Phenomenon Patients.

Horikoshi M, Inokuma S, Kijima Y, Kobuna M, Miura Y, Okada R, Kobayashi S.

Intern Med. 2016;55(5):461-6. doi: 10.2169/internalmedicine.55.5218. Epub 2016 Mar 1.

7.

The severity of peripheral blood eosinophilia indicates an eosinophilia-associated disease corresponding to its level.

Okada R, Nakachi S, Inokuma S.

Allergol Int. 2016 Jan;65(1):112-4. doi: 10.1016/j.alit.2015.07.006. Epub 2015 Aug 20. No abstract available.

8.

Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis.

Harigai M, Ishiguro N, Inokuma S, Mimori T, Ryu J, Takei S, Takeuchi T, Tanaka Y, Takasaki Y, Yamanaka H, Watanabe M, Tamada H, Koike T.

Mod Rheumatol. 2016 Jul;26(4):491-8. doi: 10.3109/14397595.2015.1123211. Epub 2016 Jan 8.

9.

Atypical Subacute Recurrence of Catastrophic Antiphospholipid Syndrome in a Japanese Female Patient.

Horikoshi M, Inokuma S, Matsubara E, Honda Y, Okada R, Kobuna M, Miura Y, Kobayashi S, Kawai S, Kumasaka T.

Intern Med. 2015;54(22):2923-7. doi: 10.2169/internalmedicine.54.5150. Epub 2015 Nov 15.

10.

Eosinophilic granulomatosis with polyangiitis demonstrating IgE-immune complexes and the possible involvement of IgE autoantibodies.

Ota Y, Fujiwara M, Hirabayashi Y, Kumasaka T, Takemura T, Ota R, Suzuki M, Inokuma S.

Intern Med. 2015;54(20):2687-91. doi: 10.2169/internalmedicine.54.4588. Epub 2015 Oct 15.

11.

Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients.

Sasaki T, Nakamura W, Inokuma S, Matsubara E.

Clin Rheumatol. 2016 Feb;35(2):541-5. doi: 10.1007/s10067-015-2865-6. Epub 2015 Feb 3. Review.

PMID:
25644583
12.

Trend of patient characteristics and its impact on the response to adalimumab in patients with rheumatoid arthritis: post hoc time-course analysis of an all-case PMS in Japan.

Yamanaka H, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, Tanaka Y, Suzuki H, Shinmura Y, Koike T.

Mod Rheumatol. 2015 Jul;25(4):495-502. doi: 10.3109/14397595.2014.994263. Epub 2015 Jan 13.

PMID:
25487291
13.

[Strategy for surgery in familial adenomatous polyposis patients with invasive colorectal cancer].

Matsuzawa T, Hatano S, Ishiguro T, Kumamoto K, Baba H, Kumagai Y, Ishibashi K, Takeuchi I, Inokuma S, Ishida H.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2050-2. Japanese.

PMID:
24394009
14.

[Analysis of KRAS status in cancer tissue with submucosal or deeper invasion in patients with familial adenomatous polyposis].

Tajima Y, Kumamoto K, Takeuchi I, Baba H, Ishibashi K, Tsuji Y, Haga N, Inokuma S, Iwama T, Ishida H.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2047-9. Japanese.

PMID:
24394008
15.

[Effect of chemotherapy in primary tumor of MSI-H colon cancer aged 50 years or younger].

Chika N, Ishibashi K, Kumamoto K, Okada N, Suzuki O, Hatano S, Amano K, Matsuzawa T, Kuwabara K, Sobajima J, Kumagai Y, Baba H, Haga N, Iwama T, Ishida H, Inokuma S, Takeuchi I.

Gan To Kagaku Ryoho. 2013 Nov;40(12):2035-7. Japanese.

PMID:
24394004
16.

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of 7740 patients.

Koike T, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, Yamanaka H, Haruna S, Ushida N, Kawana K, Tanaka Y.

Mod Rheumatol. 2014 May;24(3):390-8. doi: 10.3109/14397595.2013.843760. Epub 2013 Nov 6.

PMID:
24252049
17.

Effectiveness and safety of tocilizumab: postmarketing surveillance of 7901 patients with rheumatoid arthritis in Japan.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Sano Y, Yaguramaki H, Yamanaka H.

J Rheumatol. 2014 Jan;41(1):15-23. doi: 10.3899/jrheum.130466. Epub 2013 Nov 1.

18.

Safety and effectiveness of 6 months' etanercept monotherapy and combination therapy in Japanese patients with rheumatoid arthritis: effect of concomitant disease-modifying antirheumatic drugs.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Hirose T, Yoshinaga T, Suzukawa M.

J Rheumatol. 2013 Oct;40(10):1658-68. doi: 10.3899/jrheum.120490. Epub 2013 Aug 1.

PMID:
23908446
19.

Cut-off levels of salivary beta2-microglobulin and sodium differentiating patients with Sjögren's syndrome from those without it and healthy controls.

Asashima H, Inokuma S, Onoda M, Oritsu M.

Clin Exp Rheumatol. 2013 Sep-Oct;31(5):699-703. Epub 2013 Jun 26.

PMID:
23806216
20.

Serum β2-microglobulin level is a useful indicator of disease activity and hemophagocytic syndrome complication in systemic lupus erythematosus and adult-onset Still's disease.

Wakabayashi K, Inokuma S, Matsubara E, Onishi K, Asashima H, Nakachi S, Hagiwara K.

Clin Rheumatol. 2013 Jul;32(7):999-1005. doi: 10.1007/s10067-013-2220-8. Epub 2013 Mar 16.

PMID:
23504210
21.

Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patients.

Onoda M, Inokuma S, Arai S.

Rheumatol Int. 2013 Jun;33(6):1437-42. doi: 10.1007/s00296-012-2557-3. Epub 2012 Nov 21.

PMID:
23179258
22.

Eplerenone, an aldosterone blocker, is more effective in reducing blood pressure in patients with, than without, metabolic syndrome.

Suzuki H, Shuto H, Shuto C, Ohara I, Inokuma S, Abe Y, Sukigara M.

Ther Adv Cardiovasc Dis. 2012 Aug;6(4):141-7. doi: 10.1177/1753944712452191. Epub 2012 Jun 29.

PMID:
22751654
23.

Step by step improvement of peripheral polyneuropathy associated with Churg-Strauss syndrome by six courses of high-dose intravenous immunoglobulin therapy.

Asashima H, Inokuma S, Yamada H.

Allergol Int. 2012 Sep;61(3):503-5. doi: 10.2332/allergolint.12-LE-0431. No abstract available.

24.

Extremely high salivary β(2) -microglobulin and Na(+) levels in a Sjögren syndrome patient.

Asashima H, Inokuma S, Nakachi S, Matsuo Y, Rokutanda R, Hagiwara K, Kobayashi S.

Int J Rheum Dis. 2012 Apr;15(2):e31-3. doi: 10.1111/j.1756-185X.2011.01678.x. Epub 2011 Oct 17. No abstract available.

PMID:
22462432
25.

Eleven cases of angioedema with eosinophilia treated in a single hospital in Japan.

Nakachi S, Inokuma S.

Allergol Int. 2012 Jun;61(2):259-63. doi: 10.2332/allergolint.11-OA-0351. Epub 2012 Feb 25.

26.

Serum KL-6 level as an indicator of active or inactive interstitial pneumonitis associated with connective tissue diseases.

Doishita S, Inokuma S, Asashima H, Nakachi S, Matsuo Y, Rokutanda R, Kobayashi S, Hagiwara K, Satoh T, Akiyama O.

Intern Med. 2011;50(23):2889-92. Epub 2011 Dec 1.

27.

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients.

Koike T, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, Yamanaka H, Tanaka Y.

Mod Rheumatol. 2012 Aug;22(4):498-508. doi: 10.1007/s10165-011-0541-5. Epub 2011 Oct 13.

PMID:
21993918
28.

[Case report: a patient with a six-month history of fever of unknown origin, followed by various manifestations of the central nervous system, finally diagnosed as having intravascular lymphoma by random skin biopsy].

Hagiwara K, Abe Y, Sato T, Inokuma S, Akiyama O, Suzuki K, Sato H, Imakado S, Takemura T.

Nihon Naika Gakkai Zasshi. 2011 Jul 10;100(7):1956-8. Japanese. No abstract available.

PMID:
21863769
29.

Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Takei S, Tanaka Y, Ito K, Yamanaka H.

Ann Rheum Dis. 2011 Dec;70(12):2148-51. doi: 10.1136/ard.2011.151092. Epub 2011 Aug 17.

30.

Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injury.

Inokuma S.

Expert Opin Drug Saf. 2011 Jul;10(4):603-11. doi: 10.1517/14740338.2011.560835. Epub 2011 Mar 17. Review.

PMID:
21410426
31.

[Idiopathic hypereosinophilic syndrome (idiopathic HES)].

Matsuo Y, Inokuma S.

Arerugi. 2011 Jan;60(1):1-8. Review. Japanese. No abstract available.

PMID:
21346401
32.

Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Yoshinaga T, Freundlich B, Suzukawa M.

Rheumatol Int. 2012 Jun;32(6):1617-24. doi: 10.1007/s00296-011-1807-0. Epub 2011 Feb 18.

33.

Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Yoshinaga T, Freundlich B, Suzukawa M.

Rheumatol Int. 2012 Jun;32(6):1511-9. doi: 10.1007/s00296-010-1784-8. Epub 2011 Feb 16.

34.

Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis.

Koike T, Harigai M, Inokuma S, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Yoshinaga T, Freundlich B, Suzukawa M.

Mod Rheumatol. 2011 Aug;21(4):343-51. doi: 10.1007/s10165-010-0406-3. Epub 2011 Jan 25.

35.

[The prognosis and immunohistochemical evaluation of five perianal Paget's disease cases].

Amano K, Kumamoto K, Ohsawa T, Okada N, Ishibashi K, Inokuma S, Nakada H, Yokoyama M, Haga N, Ishida H.

Gan To Kagaku Ryoho. 2010 Nov;37(12):2653-5. Japanese.

PMID:
21224669
36.

Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases.

Maruyama J, Inokuma S.

J Rheumatol. 2010 May;37(5):967-73. doi: 10.3899/jrheum.090662. Epub 2010 Mar 15.

PMID:
20231207
37.

[Analysis of ovarian metastasis of colorectal cancer--a comparison between ovarian metastasis and peritoneal metastasis without involving ovaries].

Ishii M, Ishibashi K, Ishiguro T, Kuwabara K, Ohsawa T, Okada N, Miyazaki T, Yokoyama M, Inokuma S, Ishida H.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2257-9. Japanese.

PMID:
20037388
38.

[Expression of dihydropyrimidine dehydrogenase in primary colorectal cancer and liver metastasis--a relationship between mRNA levels in cancer cells and protein levels in cancerous tissue and effect of 5-fluorouracil].

Ishibashi K, Sobajima J, Ishiguro T, Ohsawa T, Okada N, Miyazaki T, Yokoyama M, Inokuma S, Ishida H.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2232-5. Review. Japanese.

PMID:
20037380
39.

[Treatment for intrapelvic recurrence of rectal cancer--resection versus chemotherapy].

Ishibashi K, Hokama N, Ishiguro T, Ohsawa T, Okada N, Miyazaki T, Yokoyama M, Inokuma S, Ishida H.

Gan To Kagaku Ryoho. 2009 Nov;36(12):2226-8. Japanese.

PMID:
20037378
40.

[Detection of allergen].

Kobayashi S, Inokuma S.

Nihon Rinsho. 2009 Nov;67(11):2109-14. Review. Japanese.

PMID:
19899525
41.

Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases.

Matsuyama T, Kuwana M, Matsumoto M, Isonishi A, Inokuma S, Fujimura Y.

Thromb Haemost. 2009 Aug;102(2):371-8. doi: 10.1160/TH08-12-0825.

PMID:
19652889
42.

Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis.

Sato T, Inokuma S, Sagawa A, Matsuda T, Takemura T, Otsuka T, Saeki Y, Takeuchi T, Sawada T; Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology.

Rheumatology (Oxford). 2009 Oct;48(10):1265-8. doi: 10.1093/rheumatology/kep227. Epub 2009 Aug 3.

PMID:
19651883
43.

Effects of long-acting beraprost sodium (TRK-100STP) in Japanese patients with pulmonary arterial hypertension.

Kunieda T, Nakanishi N, Matsubara H, Ohe T, Okano Y, Kondo H, Nishimura M, Shirato K, Tanabe N, Homma S, Yoshida S, Inokuma S, Kodama M, Koike T, Hishida H.

Int Heart J. 2009 Jul;50(4):513-29.

44.

Intrapulmonary hemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions.

Kobayashi S, Inokuma S.

Intern Med. 2009;48(11):891-7. Epub 2009 Jun 1.

45.

T-box 21 transcription factor is responsible for distorted T(H)2 differentiation in human peripheral CD4+ T cells.

Kaminuma O, Kitamura F, Miyatake S, Yamaoka K, Miyoshi H, Inokuma S, Tatsumi H, Nemoto S, Kitamura N, Mori A, Hiroi T.

J Allergy Clin Immunol. 2009 Apr;123(4):813-23.e3. doi: 10.1016/j.jaci.2009.01.055.

PMID:
19348920
46.

Postmarketing surveillance of the safety and effectiveness of etanercept in Japan.

Koike T, Harigai M, Inokuma S, Inoue K, Ishiguro N, Ryu J, Takeuchi T, Tanaka Y, Yamanaka H, Fujii K, Freundlich B, Suzukawa M.

J Rheumatol. 2009 May;36(5):898-906. doi: 10.3899/jrheum.080791. Epub 2009 Mar 30.

47.

Leflunomide-induced interstitial lung disease: prevalence and risk factors in Japanese patients with rheumatoid arthritis.

Sawada T, Inokuma S, Sato T, Otsuka T, Saeki Y, Takeuchi T, Matsuda T, Takemura T, Sagawa A; Study Committee for Leflunomide-induced Lung Injury, Japan College of Rheumatology.

Rheumatology (Oxford). 2009 Sep;48(9):1069-72. doi: 10.1093/rheumatology/kep052. Epub 2009 Mar 25.

PMID:
19321513
48.
49.

Effectiveness of leukocytapheresis for refractory foot ulceration in rheumatoid arthritis.

Sato T, Hagiwara K, Kobayashi S, Inokuma S, Akiyama O.

Intern Med. 2008;47(19):1763-4. Epub 2008 Oct 1. No abstract available.

50.

Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population.

Takizawa Y, Inokuma S, Tanaka Y, Saito K, Atsumi T, Hirakata M, Kameda H, Hirohata S, Kondo H, Kumagai S, Tanaka Y.

Rheumatology (Oxford). 2008 Sep;47(9):1373-8. doi: 10.1093/rheumatology/ken231. Epub 2008 Jun 24.

PMID:
18577548

Supplemental Content

Loading ...
Support Center